APLS
Apellis Pharmaceuticals, Inc.
$41.03
▲ +0.00%
NYSE · Healthcare · Biotechnology
· price updated 17d ago
Apellis Pharmaceuticals, Inc.
APLS · NYSE · Healthcare · Biotechnology · price updated 17d ago
$41.03
▲ +0.00%
AI research · $41.03
Track APLS for continuous AI research
price position
Where APLS sits now
52-week range
Low$16.61
High$41.14
Today $41.03
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$405.2M
Total debt$19.8M
Net cash after debt$385.4M
Valuation
What the market charges
Forward P/E
Price against expected earnings
No signal · Not enough data to judge
-
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
4.75x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
140.20x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
31.94x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
37.8%
ROE
Profit generated from shareholder equity
Favorable · Exceptional vs sector peers
46.0%
Debt / equity
Balance-sheet leverage
Middle ground · Lagging most sector peers
1.15x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
3.63x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How APLS compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $5.25B | 38.3 | +42.5% | 70 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Apellis Pharmaceuticals, Inc. (APLS) stock
Apellis Pharmaceuticals, Inc. tracked in the US core universe. APLS was +0.0% in the latest available session at $41.03. Its reported market value was $5.25B with a trailing P/E of 38.3. Latest reported revenue was $1.10B, changing +42.5% year over year, with $270.60M in net income.
Market snapshot updated Jul 17, 2026, 8:44 PM UTC.
- Latest available price
- $41.03
- Day change
- +0.0%
- Market cap
- $5.25B
- P/E (TTM)
- 38.3
- Revenue growth
- +42.5%
- Industry
- Biotechnology